Profiel
Alex Raeber worked as the Director of Global Research & Development at Thermo Fisher Scientific, Inc. He was also the Chief Scientific Officer & Executive Director at Benchmark Holdings Plc from 2018 to 2020.
Prior to that, he was the Head of Research & Development at Prionics AG from 2002 to 2011.
He worked as a Principal at both the University of California, Berkeley and the University of Zurich.
Raeber holds a doctorate from the University of Zurich and a graduate degree from the Swiss Federal Institute of Technology.
Eerdere bekende functies van Alex Raeber
| Bedrijven | Functie | Einde |
|---|---|---|
| BENCHMARK HOLDINGS PLC | Chief Tech/Sci/R&D Officer | 31-07-2020 |
| THERMO FISHER SCIENTIFIC | Chief Tech/Sci/R&D Officer | - |
| University of Zurich | Corporate Officer/Principal | - |
| University of California, Berkeley | Corporate Officer/Principal | - |
Prionics AG
 Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Alex Raeber
| University of Zurich | Doctorate Degree |
| Swiss Federal Institute of Technology | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| BENCHMARK HOLDINGS PLC | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Prionics AG
Prionics AG Medical SpecialtiesHealth Technology Prionics AG engages in the research in as well as the development, production, and distribution of diagnostic solutions for farm animal diseases. It focuses on diseases that can be transmitted from animals to human beings such as mad cow's disease and other prion diseases. The company was founded by Bruno Oesch and Markus Moser on February 27, 1997 and is headquartered in Schlieren, Switzerland. | Health Technology |
